IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 139 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $158,000 | -79.1% | 10,000 | -75.0% | 0.03% | -79.7% |
| Q2 2017 | $755,000 | +10.7% | 40,000 | 0.0% | 0.14% | +10.0% |
| Q1 2017 | $682,000 | +11.4% | 40,000 | 0.0% | 0.13% | +6.6% |
| Q4 2016 | $612,000 | -3.6% | 40,000 | 0.0% | 0.12% | -6.9% |
| Q3 2016 | $635,000 | +21.4% | 40,000 | 0.0% | 0.13% | +18.0% |
| Q2 2016 | $523,000 | +11.3% | 40,000 | 0.0% | 0.11% | +11.0% |
| Q1 2016 | $470,000 | +1.3% | 40,000 | 0.0% | 0.10% | +5.3% |
| Q4 2015 | $464,000 | +11.3% | 40,000 | 0.0% | 0.10% | +5.6% |
| Q3 2015 | $417,000 | -13.5% | 40,000 | 0.0% | 0.09% | -4.3% |
| Q2 2015 | $482,000 | -24.7% | 40,000 | 0.0% | 0.09% | -24.2% |
| Q1 2015 | $640,000 | +4.4% | 40,000 | 0.0% | 0.12% | +3.3% |
| Q4 2014 | $613,000 | +18.3% | 40,000 | 0.0% | 0.12% | +14.3% |
| Q3 2014 | $518,000 | -15.5% | 40,000 | 0.0% | 0.10% | -13.2% |
| Q2 2014 | $613,000 | +24.3% | 40,000 | 0.0% | 0.12% | +19.8% |
| Q1 2014 | $493,000 | – | 40,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |